Maritime Transportation Security Act of 2002

Intellian awarded contract to design and supply user terminals for Viasat Maritime

Retrieved on: 
Tuesday, November 15, 2022
ViaSat-3, Maritime Transportation Security Act of 2002, Technology, GM, Organization, Risk, Efficiency, Industry, Anomaly, Company, Running, VSAT, Viasat (American company), Securities Exchange Act of 1934, Annual report, Samsung NX series, CEO, NASDAQ, Maritime, VP, Atmosphere, Engineering, GEO, Securities Act of 1933, Solution, Communications satellite, Satellite navigation device, Viasat

FORT LAUDERDALE, Fla., Nov. 15, 2022 /PRNewswire/ -- Viasat Inc., a global communications company (NASDAQ: VSAT), and Intellian, a leading provider of feature-rich, future proof satellite communications solutions, today announced a contract award for Intellian to design and supply a bespoke range of Ka-band user terminals exclusively for Viasat's Maritime connectivity solution.

Key Points: 
  • FORT LAUDERDALE, Fla., Nov. 15, 2022 /PRNewswire/ -- Viasat Inc., a global communications company (NASDAQ: VSAT), and Intellian, a leading provider of feature-rich, future proof satellite communications solutions, today announced a contract award for Intellian to design and supply a bespoke range of Ka-band user terminals exclusively for Viasat's Maritime connectivity solution.
  • In addition to the bespoke new terminals, Intellian will also develop a 100cm upgrade kit for Intellian's popular NX Series.
  • With many world-firsts and industry leading innovations, Intellian has quickly garnered the reputation for engineering excellence through their customer-centric approach.
  • Viasat, the Viasat logo and the Viasat signal are registered trademarks of Viasat, Inc. All other product or company names mentioned are used for identification purposes only and may be trademarks of their respective owners.

Six New Dealers Signed by AITX’s Subsidiary Robotic Assistance Devices

Retrieved on: 
Thursday, November 10, 2022
Name, AVA, Theft, ROSA, Sale, Solution, Securities Exchange Act of 1934, Company, Transport, Technology, Maritime Transportation Security Act of 2002, Area studies, Industry, Forward-looking statement, Challenge, GSX, Securities Act of 1933, ROI, News, OTCQB, Government, CEO, RoboCop (franchise), RAD, Private Securities Litigation Reform Act, RIO, NJB, GLOBE, New, American Securities, Economics, Education, Organization, Robotics, Artificial intelligence, Automation, LLC, 3D printing, Financial adviser, Risk management

Detroit, Michigan, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc., (the Company) (OTCPK:AITX), today announced that its wholly owned subsidiary, Robotic Assistance Devices, Inc. (RAD) has signed 6 new authorized dealers.

Key Points: 
  • RADs Dealer Network Continues to Grow, now 52 Authorized Dealers
    Detroit, Michigan, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc., (the Company) ( OTCPK:AITX ), today announced that its wholly owned subsidiary, Robotic Assistance Devices, Inc. (RAD) has signed 6 new authorized dealers.
  • Security dealers and integrators are so close to the end-users problems, said Mark Folmer, President of RAD.
  • These six new dealers have already added to RADs sales pipeline, and we look forward to supporting every opportunity.
  • Through its next-generation robotic product offerings, AITXs RAD, RAD-M and RAD-G companies help organizations streamline operations, increase ROI, and strengthen business.

IO Biotech Announces an Invited Oral Presentation and Two Poster Presentations with New Preclinical Data for Additional Pipeline Candidates at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting

Retrieved on: 
Wednesday, November 9, 2022
GLOBE, TGF beta 1, Investigational New Drug, IO, TGF beta 2, Forward-looking statement, IND, Vaccine, Tumor microenvironment, Annual general meeting, Nasdaq, Peptide, EST, Immunotherapy, IDO, Center, ARG1, Society for Immunotherapy of Cancer, Securities Act of 1933, Cancer, Herlev Hospital, PD-L1, Securities Exchange Act of 1934, SITC, Time, Vaccination, Science, Transforming growth factor, beta 3, Cell, Patient, TME, Maritime Transportation Security Act of 2002, Society, Antigen, Communications satellite

NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune-modulating anti-cancer therapies based on its proprietary T-win® technology, today announced details of the invited oral presentation and two poster presentations at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting.

Key Points: 
  • Information for the invited oral presentation:
    Session: Concurrent Session 119 Vaccines: In Situ Agents and Novel Systemic Approaches
    Presenter: Mads Hald Andersen, Ph.D.
  • We see the potential of these two new candidates to build on the strength of our T-win platform and a path forward for Investigational New Drug filings.
  • These preclinical data support further development of a TGF1 vaccine as a TME targeted approach for the treatment of a wide range of cancers.
  • IO Biotech is advancing in clinical studies its lead immuno-oncology candidate, IO102-IO103, targeting IDO and PD-L1, and through preclinical development its other pipeline candidates.

Viasat and Cobham Satcom Announce Strategic Collaboration on Maritime Connectivity System Ahead of ViaSat-3

Retrieved on: 
Thursday, November 10, 2022
Anomaly, YouTube, Corporate blog, VSAT, Risk, Partnership, Cobham, Securities Act of 1933, Oil, Ka band, ViaSat-3, Viasat (American company), Atmosphere, NASDAQ, Annual report, Solution, Maritime, Securities Exchange Act of 1934, Senior, Gas, Company, GM, Internet, Social media, Radio, Fossil fuel, Maritime Transportation Security Act of 2002, VP, Industry, Ka, Communications satellite, Cruise, Viasat, Mediterranean Sea

The connectivity system, which will include a portfolio of groundbreaking antenna systems from Cobham Satcom, is being meticulously designed to deliver advanced, high-speed connectivity that will leverage the immense satellite capacity expected from the ViaSat-3 constellation.

Key Points: 
  • The connectivity system, which will include a portfolio of groundbreaking antenna systems from Cobham Satcom, is being meticulously designed to deliver advanced, high-speed connectivity that will leverage the immense satellite capacity expected from the ViaSat-3 constellation.
  • In addition, the collaboration will include the introduction of the industry first upgrade kit, which will allow conversion of existing Ku and other Ka band services to Viasat services.
  • Viasat and Cobham Satcom will work with Cobham Satcom's broad global distribution network to provide customers professional fit for purpose pre-sales and after-sales support.
  • "Building off our long-standing relationship, we have beenable to closely collaborate during Cobham Satcom's development of next-generation terminals to optimize the broadband connectivity experience on our future satellites," said Shameem Hashmi, VP and GM, Maritime, Viasat.

Rocket Lab Awarded $14m in Contracts to Supply Satellite Separation Systems for Space Development Agency’s Tranche 1 Transport Layer

Retrieved on: 
Wednesday, November 9, 2022
Satellite, Software, Hardware, Engineering, Technology, Aerospace, Manufacturing, Other Technology, Neutron, Orbit, Private Securities Litigation Reform Act, Phrase, Technology readiness level, U.S. Securities and Exchange Commission, Space Shuttle, Pandemic, Epidemic, Risk, Environment, NDSA, Congestion, Federal government of the United States, Rocket Lab, COVID-19, Privacy and the US government, Securities Act of 1933, Spacecraft, SSL (company), SEC, Failure, Solution, Government, Securities Exchange Act of 1934, Shock, Contract, Company, Technology, Electron, NASA, Maritime Transportation Security Act of 2002, Moon, Martin Lightband, Security (finance), Industry, SDA, Lab, Communications satellite, Mars, Photon, Satellite, Software, Hardware, Engineering, Technology, Aerospace, Manufacturing, Other Technology

Rocket Lab USA, Inc. (Nasdaq: RKLB) (Rocket Lab or the Company), a leading launch and space systems company, has been awarded two contracts worth a total of $14 million to provide satellite separation systems for Space Development Agencys (SDA) Tranche 1 Transport Layer (T1TL) satellites.

Key Points: 
  • Rocket Lab USA, Inc. (Nasdaq: RKLB) (Rocket Lab or the Company), a leading launch and space systems company, has been awarded two contracts worth a total of $14 million to provide satellite separation systems for Space Development Agencys (SDA) Tranche 1 Transport Layer (T1TL) satellites.
  • Rocket Lab will supply more than 80 total Lightband Separation Systems (Lightbands) to prime contractor Lockheed Martin and another an undisclosed customer, both of whom are manufacturing satellites for the SDAs Tranche 1 Transport Layer.
  • Lightbands are separation systems that are used to attach satellites to rockets and release them in space once the rocket reaches its intended orbit.
  • Rocket Labs separation systems were designed by Planetary Systems Corp, which was acquired by the Company in 2021, and have a 100% mission success rate across more than 140 missions.

Rocket Lab Announces Launch Window for Inaugural Electron Mission from Launch Complex 2 in Virginia

Retrieved on: 
Wednesday, November 9, 2022
Technology, Satellite, Transport, Aerospace, Manufacturing, Other Transport, Neutron, Private Securities Litigation Reform Act, Launch, Phrase, History, Mid-Atlantic Regional Spaceport, Main Street, Cyprus Securities and Exchange Commission, Pandemic, Epidemic, Beach Road, Risk, Environment, Multimedia, Rocket Lab, COVID-19, Securities Act of 1933, Spacecraft, SEC, HawkEye 360, Securities Exchange Act of 1934, Company, Government, Soil, Launch Complex 1, Radio, Launch Complex 2, CEO, Electron, NASA, United States Department of Defense, Maritime Transportation Security Act of 2002, Moon, Security (finance), Industry, Lab, Hawk-Eye, Rocket Lab Electron, Communications satellite, Mars, Wallop (disambiguation), Assateague Island National Seashore, Photon

Rocket Lab USA, Inc. (Nasdaq: RKLB) (Rocket Lab or the Company), a leading launch and space systems company, today announced it is scheduled to launch its first Electron mission from Virginia during a launch window opening December 7 EST.

Key Points: 
  • Rocket Lab USA, Inc. (Nasdaq: RKLB) (Rocket Lab or the Company), a leading launch and space systems company, today announced it is scheduled to launch its first Electron mission from Virginia during a launch window opening December 7 EST.
  • View the full release here: https://www.businesswire.com/news/home/20221109005960/en/
    Rocket Lab's Electron launch vehicle arrives at Launch Complex 2 in preparation for a December 7 launch window.
  • Launch Complex 2 supplements Rocket Labs existing site, Launch Complex 1 in New Zealand, from which 31 Electron missions have already launched.
  • Rocket Lab has three launch pads at two launch sites, including two launch pads at a private orbital launch site located in New Zealand and a second launch site in Virginia, USA which is expected to become operational in 2022.

Relmada Therapeutics to Report Third Quarter 2022 Financial Results and Host Conference Call and Webcast on November 10, 2022

Retrieved on: 
Tuesday, November 8, 2022
NMDA, NMDAR, Risk, MDD, Neurodegeneration, Phrase, Patient, Nature, SEC, Company, Private Securities Litigation Reform Act, Securities Exchange Act of 1934, Maritime Transportation Security Act of 2002, NCE, Securities Act of 1933, CNS, Central nervous system, Psilocybin, Therapy, Safety, Failure, Pharmaceutical industry

The ongoing Reliance Clinical Research Program is designed to evaluate the potential for REL-1017 as a rapid-acting, oral, once-daily adjunctive antidepressant treatment.

Key Points: 
  • The ongoing Reliance Clinical Research Program is designed to evaluate the potential for REL-1017 as a rapid-acting, oral, once-daily adjunctive antidepressant treatment.
  • In a Phase 2 trial, REL-1017 demonstrated rapid, robust, and sustained adjunctive antidepressant effects with statistically significant improvements compared to placebo.
  • The Phase 2 study also showed a favorable pharmacokinetic, safety, and tolerability profile of REL-1017 consistent with results observed in previously completed Phase 1 studies.
  • Relmada Therapeutics is a late-stage biotechnology company addressing diseases of the central nervous system (CNS), with a focus on major depressive disorder (MDD).

Palantir Continues Expansion in Australia with WesTrac Partnership

Retrieved on: 
Tuesday, November 8, 2022
Environment, Software, Workflow, U.S. Securities and Exchange Commission, NYSE, Technology, Government, Rio Tinto, Natural Resources, Securities Exchange Act of 1934, Maritime Transportation Security Act of 2002, WesTrac, Forward-looking statement, Time, Securities Act of 1933, Seven West Media, Partnership, Efficiency, PLTR, Solution, Mining, Commercial, Security (finance), Safety, Organic, Community, Risk management, Palantir Technologies

CANBERRA, Australia and PERTH, Australia, Nov. 8, 2022 /PRNewswire/ -- Palantir Technologies Inc. (Palantir, NYSE: PLTR), a leading builder of operating systems for the modern enterprise, and WesTrac, a leading provider of heavy mobile equipment and aftermarket services to the Australian mining and construction sectors, today announced a partnership to deploy Palantir Foundry across WesTrac's servicing and rebuild operations centres in Perth, Western Australia.

Key Points: 
  • CANBERRA, Australia and PERTH, Australia, Nov. 8, 2022 /PRNewswire/ -- Palantir Technologies Inc. (Palantir, NYSE: PLTR), a leading builder of operating systems for the modern enterprise, and WesTrac, a leading provider of heavy mobile equipment and aftermarket services to the Australian mining and construction sectors, today announced a partnership to deploy Palantir Foundry across WesTrac's servicing and rebuild operations centres in Perth, Western Australia.
  • WesTrac and Palantir first began collaboration in 2021, and the current formal agreement will eventually expand to include WesTrac workshops in New South Wales.
  • "Palantir Foundry will help transform WesTrac by providing unique insight into its critical operational and manufacturing decisions."
  • "The WesTrac team are delighted to be working with Palantir on a project that will further digitalise our rebuild operations" said Jarvas Croome, Chief Executive Officer of WesTrac.

Werner Enterprises Expands and Diversifies its Logistics Capabilities with the Acquisition of ReedTMS Logistics

Retrieved on: 
Monday, November 7, 2022
Company, Private Securities Litigation Reform Act, Transport, Culture, GLOBE, Method, Werner Enterprises, Webcast, Dedicated, Securities Exchange Act of 1934, Nasdaq, LLP, CEO, Securities Act of 1933, WERN, Food, U.S. Securities and Exchange Commission, Logistics, Maritime Transportation Security Act of 2002, Acquisition, Goal, News, Solution, Cargo

ReedTMS Logistics further strengthens our freight brokerage capabilities, said Derek Leathers, Chairman, President and Chief Executive Officer.

Key Points: 
  • ReedTMS Logistics further strengthens our freight brokerage capabilities, said Derek Leathers, Chairman, President and Chief Executive Officer.
  • We are excited to join the Werner team, who we have always considered an industry leader, said Jason Reed, CEO of ReedTMS Logistics.
  • We look forward to jointly growing our combined logistics business with Werner, said Mark Reed, Jr., President of ReedTMS Logistics.
  • Werner Enterprises will conduct a conference call to discuss the ReedTMS acquisition today at 1:00 p.m. CT.

Aehr Receives Over $4 Million in Orders for its FOX WaferPak™ Full Wafer Contactors to Support Production Test and Burn-in of Silicon Carbide Power Semiconductors for Electric Vehicles

Retrieved on: 
Friday, November 4, 2022
3D, Industry, GLOBE, Form 10-K, Memory, Logic, Electric Bond and Share Company v. Securities and Exchange Commission, 2D, Securities Exchange Act of 1934, Gallium nitride, Efficiency, AEHR, Carrier, ABTS, Silicon, CEO, Securities Act of 1933, Contactor, Forward-looking statement, Automotive industry, NASDAQ, Maritime Transportation Security Act of 2002, Percussion section, Mobility, FOX, Security (finance), Traction, Ceramic, Printed circuit board

These WaferPak Contactors are expected to ship by the end of Aehrs fiscal third quarter ending February 28, 2023.

Key Points: 
  • These WaferPak Contactors are expected to ship by the end of Aehrs fiscal third quarter ending February 28, 2023.
  • Aehr Test has developed and introduced several innovative products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.
  • The WaferPak contactor contains a unique full wafer probe card capable of testing wafers up to 300mm that enables IC manufacturers to perform test and burn-in of full wafers on Aehr Test FOX systems.
  • Aehr disclaims any obligation to update information contained in any forward-looking statement to reflect events or circumstances occurring after the date of this press release.